Timing of the hepatic arterial phase during contrast-enhanced computed tomography of the liver: Assessment of normal values in 25 volunteers

Investigative Radiology

Volumn 35, Issue 8, 2000, Pages 486-492

  Bader, Till R ^a   Prokesch, Rupert W ^a   Grabenwöger, Florian ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Contrast enhancement, blood; Contrast media, CT; CT; Flow dynamics; Helical CT; Liver

Indexed keywords

CONTRAST MEDIUM; IOPROMIDE;

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD RHEOLOGY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HEPATIC ARTERY; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; LIVER; LIVER CIRCULATION; MALE; PRIORITY JOURNAL;

EID: 0033858936     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200008000-00005     Document Type: Article

References (30)

1. Hepatic perfusion: New perspectives at computed tomography
2. Difference in global hepatic enhancement assessed by dynamic CT in normal subjects and patients with hepatic metastases
3. Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms
4. Hepatic lesion characterization in cirrhosis: Significance of arterial hypervascularity on dual-phase helical CT
5. Nodular hepatocellular carcinomas: Detection with arterial-, portal-, and delayed-phase images at spiral CT
6. Dual-phase helical CT of nonfunctioning islet cell tumors
7. Carcinoid metastases to the liver: Role of triple-phase helical CT
8. CT of hypervascular hepatic tumors: Are unenhanced scans necessary for diagnosis?
9. Hepatocellular carcinoma: The role of helical biphasic contrast-enhanced CT versus CT during arterial portography
10. Detecting hepatocellular carcinoma: Value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging
11. Helical biphasic contrast-enhanced CT of the liver: Technique, indications, interpretation, and pitfalls
12. Understanding and optimizing use of contrast material for CT of the liver
13. Aortic and hepatic contrast medium enhancement at CT, part I: Prediction with a computer model
14. Hepatic CT enhancement, II: Alterations in contrast material volume and rate of injection within the same patients
15. Prediction of the time to peak hepatic enhancement to optimize contrast-enhanced spiral CT
16. Effect of rate of contrast medium injection on hepatic enhancement at CT
17. Effects of injection rates of contrast material on arterial phase hepatic CT
18. Effective contrast use in CT angiography and dual-phase hepatic CT performed with a subsecond scanner
19. Application of pharmacokinetics to computed tomography: Injection rates and schemes: Mono-, bi-, or multiphasic?
20. Aortic and hepatic contrast medium enhancement at CT. Part II: Effect of reduced cardiac output in a porcine model
21. Bolus dynamics: Theoretical and experimental aspects
22. Dynamic incremental CT: Effect of volume and concentration of contrast material and patient weight on hepatic enhancement
23. Bolus geometry and dynamics after intravenous contrast medium injection
24. Dynamic contrast enhancement of the upper abdomen: Effect of contrast medium and body weight
25. Posttraumatic shock in children: CT findings associated with hemodynamic instability
26. Contrast-enhanced spiral CT of the liver: Effect of different amounts and injection rates of contrast material on early contrast enhancement
27. Dynamic helical CT of the abdomen: Prospective comparison of pre- and postprandial contrast enhancement
28. Optimal contrast enhancement of the liver using helical (spiral) C.T. Value of Smart Prep
29. Bolus tracking and NaC1 bolus in biphasic spiral CT of the abdomen